An Indiana Toddler Died From Rocky Mountain Spotted Fever — What To Know About This Tick-Borne Infection
By Jessica Migala It’s a heartbreaking story: an Indiana girl just shy of her third birthday has died of organ failure caused by Rocky Mountain Spotted Fever (RMSF). Doctors didn’t realize Kenley Ratliff contracted the tick-borne illness until it was too late for the antibiotics to work. Now, her devastated family, along with health officials, are sounding the alarm about this sometimes lethal infection, which despite its name isn’t limited to the Rocky Mountains. “If we could save one child’s life then we will have done our job,” Jordan Clapp, Kenley’s aunt told Today. RELATED: 15 Important Facts You Must Know About Ticks While you dry your eyes, consider Kenley’s story to be a wakeup call about RMSF, cases of which have been on the rise over the past decade, reports the Centers for Disease Control and Prevention. When it comes to tick-transmitted illnesses, Lyme disease is the one that gets the media spotlight. But lesser-known RMSF is actually more serious. “The issue with Rocky Mountain Spotted Fever is, unlike many other tick-borne diseases, it’s more severe and can cause death,” says Colleen Nash, MD, MPH, a pediatric infectious diseases specialist at Rush University Medical Center in Chicago. When it comes to tick-transmitted illnesses, Lyme disease is the one that gets the media spotlight. But lesser-known RMSF is actually more serious. What is Rocky Mountain Spotted Fever? Differen...
Intranasal ketamine is a viable treatment option for acute cluster headache attacks ― but does not reduce pain intensity as quickly as initially anticipated, a new pilot study suggests.Medscape Medical News
Condition: Migraine Interventions: Drug: Rimegepant; Drug: Various; Other: No intervention Sponsors: Biohaven Pharmaceuticals, Inc.; Biohaven Pharmaceutical Holding Company Ltd. Active, not recruiting
Conditions: Headache; Urinary Incontinence; Growth Deficiency; Visual Impairment; Psychomotor Retardation, Mild to Severe; Demyelinating Diseases; Brain Tumor Interventions: Other: Information leaflet; Other: Educational movie; Other: Demonstration Sponsors: Children's Memorial Health Institute, Poland; Siemens Healthcare Sp. z o.o. Recruiting
Conditions: Migraine; Headache Disorders, Primary Intervention: Other: Ultrasound guided greater occipital nerve (GON) radiofrequency Sponsor: Tepecik Training and Research Hospital Completed
We report an unusual head tumour with extremely rare extensiveness and aggressivness. The patient was 18-year-old female with three-day-lasting headache and repetitive oral bleeding. Computed tomography revealed a large, well-circumscribed, expansile mass occupying ethmoid cells, nasal cavities and ventral part of the sphenoid sinus, with extention into the anterior cranial fossa. Pterional craniotomy was carried out. On one-year follow-up recurrence of the lesion was identified and the second surgery was performed. The lesion is under supervision now, due to incomplete removal.PMID:35048642 | DOI:10.5114/pjp.2021.111779
Pract Neurol. 2022 Jan 19:practneurol-2021-003194. doi: 10.1136/practneurol-2021-003194. Online ahead of print.ABSTRACTPosterior reversible encephalopathy syndrome (PRES) may present with diverse clinical symptoms including visual disturbance, headache, seizures and impaired consciousness. MRI shows oedema, usually involving the posterior subcortical regions. Triggering factors include hypertension, pre-eclampsia/eclampsia, renal failure, cytotoxic agents and autoimmune conditions. The mechanism underlying PRES is not certain, but endothelial dysfunction is implicated. Treatment is supportive and involves correcting the un...
Br J Dermatol. 2022 Jan 19. doi: 10.1111/bjd.21024. Online ahead of print.NO ABSTRACTPMID:35048359 | DOI:10.1111/bjd.21024
ConclusionsOur results might help physicians identify early symptoms, comorbidities, and risk factors related to mortality in CVD patients hospitalized for COVID-19.
Staffing is the issue keeping NHS leaders awake at night – and which consumes two-thirds of trusts’ spending. The fortnightly The Ward Round newsletter, by HSJ workforce correspondent Annabelle Collins, ensures you are tuned in to the daily pressures on staff, and the wider trends and policies shaping the workforce.
Individuals with the fragile X premutation report symptoms of chronic pain from multiple systems, have increased incidence of comorbid conditions where pain is a prominent feature, and pathophysiology that supports disrupted pain regulation, inflammation, and energy imbalance. Less is known about how pain manifests for the subpopulation of carriers that develop the motor and cognitive changes of fragile X-associated tremor and ataxia syndrome (FXTAS), and how pain may differ between men and women. We gathered data collected from 104 males and females with FXTAS related to chronic pain, comorbid conditions related to pain, ...